| Nb | Pat | Sex | Age | Primary disease | BiP Treatment | Length of BiP treatment (months) | Triggering cause of BRONJ | Osteonecrotic area | ONJ Classification | Time between start of BiP intake and BRONJ diagnosis (months) | Time between end of BiP intake and BRONJ diagnosis (months) | Time between surgery and last follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MA | F | 79 | Breast cancer | Zoledronate (Zometa) | 15 | Extraction of # 43, 44 | Mandible, Left anterior area | ONJ 3 | 39 | 0.5 | 27, deceased |
| 2 | IG | F | 77 | Osteoporosis | Alendronate (Fosavance) | 35 | Extraction of # 46 | Mandible, Posterior at # 46 | ONJ 2/3 | 88 | 0 | 38 |
| 3 | DF | M | 68 | Multiple myeloma | Zoledronate (Zometa) | 38 | Extraction of # 36,37, 46,47 | Mandible, Bilat. posterior at # 36,37 & 46,47 | ONJ 3 | 110 | 6 | 32 |
| 4 | BA | M | 77 | Prostate cancer | Zoledronate (Zometa) | 33 | Traumatic ill-fitted prosthesis | Mandible, Anterior at # 33,34 | ONJ 2 | 90 | 3 | 26 |
| 5 | SM | F | 81 | Osteoporosis | Alendronate (Fosavance) | 32 | Extraction of # 11,12 | Maxilla, Anterior at # 11,12 | ONJ 2 | 80 | 0 | 23 |
| 6 | GP | M | 60 | Multiple myelome | Zoledronate (Zometa) | 20 | Extraction of # 16,17 | Maxilla, Posterior at # 16,17 | ONJ 3 | 53 | 1 | 15 |
| 7 | NL | F | 69 | Osteoporosis | Alendronate (Alendros 70) | 70 | Extraction of # 47 | Mandible, Posterior at # 47 | ONJ 2 | 183 | 3 | 14 |
| 8 | MS | F | 59 | Multiple myelome | Zoledronate (Zometa) | 13 | Extraction of # 43, 44 | Mandible, Left anterior area | ONJ 2 | 35 | 1 | 13 |